Ethical Drug Development for Rare Childhood Diseases: When There Are Limited But Promising Data in Adults, How to Choose Between Safety or Efficacy Studies?

समान संसाधन

• Clearing Muddy Waters: The Need to Reconceptualize Minor Increase over Minimal Risk in Pediatric Rare Disease Research
  द्वारा: Duenas, Devan M., और अन्य
  प्रकाशित: (2020)
• Greater Than Minimal Risk, No Direct Benefit – Bridging Drug Trials and Novel Therapy in Pediatric Populations
  द्वारा: Wilfond, Benjamin S., और अन्य
  प्रकाशित: (2020)
• Conflicts of Interest and Recommendations for Clinical Treatments That Benefit Researchers
  द्वारा: Wilfond, Benjamin S., और अन्य
  प्रकाशित: (2020)
• Click Here to Complete This Survey: Online Research, Adolescents, and Parental Consent
  द्वारा: Johnson, Liza-Marie, और अन्य
  प्रकाशित: (2020)
• Choosing Schools, Choosing Safety: How Multiple Dimensions of Safety Shape School Choices
  द्वारा: Chantal A. Hailey
  प्रकाशित: (2025-04-01)